Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Serrano

Showing results (201-210 of 223) with videos related to

Pageof 23
Sort By:
Scientific Reports|July 13, 2025
Impact of the initial administration of an antiretroviral drug with latency reversal properties on the HIV reservoir sizeErick De La Torre Tarazona, Elisa Moraga, Raúl Vaquer, et al.
Plos Pathogens|March 26, 2016
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized TrialSergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, et al.
AIDS (London, England)|November 26, 2019
Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapyTalia Sainz, Sergio Serrano-Villar, Surinder Mann, et al.
Nature Medicine|July 18, 2023
Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancerSergio Serrano-Villar, Camilla Tincati, Sajan C Raju, et al.
Nature Medicine|August 16, 2023
Author Correction: Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancerSergio Serrano-Villar, Camilla Tincati, Sajan C Raju, et al.
Microbiome|May 23, 2025
Metaproteomics in the One Health framework for unraveling microbial effectors in microbiomesRobert Heyer, Maximilian Wolf, Dirk Benndorf, et al.
Plos Pathogens|May 4, 2017
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized TrialSergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, et al.
Plos Pathogens|January 23, 2016
Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized TrialSergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, et al.
Nature Communications|February 19, 2021
Fecal microbiota transplantation in HIV: A pilot placebo-controlled studySergio Serrano-Villar, Alba Talavera-Rodríguez, María José Gosalbes, et al.
International Journal of Molecular Sciences|September 13, 2025
Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir SizeErick De La Torre Tarazona, Elisa Moraga, María Fons-Contreras, et al.
Pageof 23

Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
Scientific Reports|July 13, 2025
Impact of the initial administration of an antiretroviral drug with latency reversal properties on the HIV reservoir sizeErick De La Torre Tarazona, Elisa Moraga, Raúl Vaquer, et al.
Plos Pathogens|March 26, 2016
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized TrialSergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, et al.
AIDS (London, England)|November 26, 2019
Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapyTalia Sainz, Sergio Serrano-Villar, Surinder Mann, et al.
Nature Medicine|July 18, 2023
Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancerSergio Serrano-Villar, Camilla Tincati, Sajan C Raju, et al.
Nature Medicine|August 16, 2023
Author Correction: Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancerSergio Serrano-Villar, Camilla Tincati, Sajan C Raju, et al.
Microbiome|May 23, 2025
Metaproteomics in the One Health framework for unraveling microbial effectors in microbiomesRobert Heyer, Maximilian Wolf, Dirk Benndorf, et al.
Plos Pathogens|May 4, 2017
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized TrialSergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, et al.
Plos Pathogens|January 23, 2016
Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized TrialSergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, et al.
Nature Communications|February 19, 2021
Fecal microbiota transplantation in HIV: A pilot placebo-controlled studySergio Serrano-Villar, Alba Talavera-Rodríguez, María José Gosalbes, et al.
International Journal of Molecular Sciences|September 13, 2025
Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir SizeErick De La Torre Tarazona, Elisa Moraga, María Fons-Contreras, et al.
Pageof 23